Clinical trial
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
NCT06076304 is registered in ClinicalTrials.gov with Daniel Merenstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
- Lead sponsor
- Daniel Merenstein
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 21, 2023
- Completion date
- December 31, 2028
- Enrollment
- 3,720 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
acute sinusitis, sinus infection